Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.600
-0.130 (-4.76%)
At close: Jul 24, 2026, 4:00 PM EDT
2.590
-0.010 (-0.38%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $399 million as of July 24, 2026. Its market cap has increased by 37.75% in one year.
Market Cap
399.00M
Enterprise Value
292.65M
1-Year Change
37.75%
Ranking
Category
Stock Price
$2.60
ChartMarket Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $620.67M to $399.00M, a decrease of -35.71%. That is a compound annual growth rate of -4.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 399.00M | 99.38% |
| Dec 31, 2025 | 200.12M | 90.89% |
| Dec 31, 2024 | 104.84M | -87.33% |
| Dec 29, 2023 | 827.35M | 38.68% |
| Dec 30, 2022 | 596.59M | -66.78% |
| Dec 31, 2021 | 1.80B | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 417.53M |
| Ocugen | 409.61M |
| Evommune | 409.17M |
| Puma Biotechnology | 406.18M |
| Benitec Biopharma | 394.04M |
| Autolus Therapeutics | 385.91M |
| vTv Therapeutics | 381.34M |
| Eupraxia Pharmaceuticals | 381.30M |